Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective

Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective

Abstract Atopic dermatitis (AD) is a common chronic, multisystem inflammatory skin disease in pediatric patients. There has been an increase in the incidence of AD in the pediatric population of the Asia–Pacific region. Studies have shown that genetic, epigenetic, environmental and cultural factors...

Full description

Bibliographic Details
Main Authors: Chia-Yu Chu, Tsung-Chieh Yao, I.-Hsin Shih, Chin-Yi Yang, Chan Lee Chin, Sabeera Begum Binti Kader Ibrahim, Suganthi Thevarajah, Leong Kin Fon, Marco Hok-Kung Ho, Chow Chung Mo, Chow Pok Yu, Steven King-Fan Loo, Thomas Luger
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-02-01
Series:Dermatology and Therapy
Subjects:
Atopic dermatitis
Pimecrolimus
Infants
Asian population
Topical calcineurin inhibitor
Online Access:https://doi.org/10.1007/s13555-022-00886-9

Internet

https://doi.org/10.1007/s13555-022-00886-9

Similar Items